A whitening nanocomposition and its preparation method and application

By using nanocarrier-bound whitening nanocompositions in whitening products, the problems of single action mechanism, poor stability and transdermal difficulties in existing whitening products are solved, and efficient and stable whitening effects are achieved.

CN118615186BActive Publication Date: 2024-11-08MENTHOLATUM (CHINA) PHARM CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411096822.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-12
Publication Date
2024-11-08
Estimated Expiration
2044-08-12

AI Technical Summary

Technical Problem

The existing whitening products have a single mechanism of action, are irritating, poor stability, and are difficult to reach the dermis through the skin barrier, resulting in poor whitening effect.

Method used

Whitening nanocompositions, including α-arbutin, nicotinamide, 3-o-ethyl ascorbic acid, Centella asiatica extract and retinol palmitate as the main active ingredients, are used to improve water dispersion by combining specific nanocarriers. and stability, enhance transdermal ability, reduce irritation, promote the arrival of components into melanocytes and sustained release.

Benefits of technology

Effectively improve the solubility and stability of whitening active ingredients, enhance transdermal ability, prolong the action time, significantly improve the whitening effect, reduce irritation, and improve bioavailability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118615186B_ABST
    Figure CN118615186B_ABST
Patent Text Reader

Abstract

This invention relates to a whitening nanocomposition, its preparation method, and its application, belonging to the technical field of cosmetics or similar grooming products. The whitening nanocomposition of this invention comprises an active ingredient and a nanocarrier, wherein the active ingredient is encapsulated and / or adsorbed by the nanocarrier; the active ingredient comprises the following components in parts by weight: 1-15 parts α-arbutin, 1-15 parts nicotinamide, 1-10 parts 3-o-ethyl ascorbic acid, 0.1-1 parts Centella asiatica extract, and 1-5 parts retinyl palmitate; the nanocarrier comprises the following components in parts by weight: 5-10 parts emulsifier, 5-20 parts polyol, 0.1-5 parts phospholipid, and 40-60 parts water. The whitening nanocomposition of this invention has good skin permeability and retention properties, enabling it to accumulate at high concentrations in target tissues, remain for extended periods, and release slowly and in a controlled manner, allowing for effective uptake by target cells, thereby improving its bioavailability and enhancing the whitening effect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of cosmetics or similar dressing preparations, and in particular to a whitening nanometer composition and a preparation method and application thereof. Background Art

[0002] The pigments in human skin mainly include dark brown melanin, red hemoglobin and yellow carotene, among which melanin is the key factor affecting skin color. External factors such as ultraviolet rays and pollution, as well as internal factors such as hormones and inflammation levels, act together on the skin, affecting the secretion of melanin by melanocytes through different mechanisms and pathways. The current whitening ingredients mainly reduce the amount of melanin in the skin through different pathways to achieve the whitening effect. The specific pathways are mainly to inhibit the activity of tyrosinase, accelerate the metabolism of stratum corneum cells that have pigmentation, and reduce the stimulation of ultraviolet rays or free radicals on melanocytes.

[0003] However, there are many types of whitening products on the market, and most products are difficult to achieve whitening effects that satisfy consumers. The main reasons include: (1) The existing whitening products have a single mechanism of action and are irritating to a certain extent. For example, although some products have strong tyrosinase inhibition and keratin exfoliation effects, they lack active ingredients for skin repair, resulting in skin barrier damage; (2) The stability of the functional ingredients with whitening function is poor. When they are directly applied to cosmetic products, they are prone to oxidative denaturation or inactivation, making it difficult to exert a whitening effect; (3) Due to the barrier function of the skin itself, it is difficult for the whitening functional ingredients to penetrate the stratum corneum and enter the dermis, and it is even more difficult for them to accumulate in the target area of ​​the skin to reach an effective concentration range, resulting in poor actual whitening skin care effects. Summary of the invention

[0004] The purpose of the present invention is to overcome the deficiencies of the prior art and provide a whitening nanocomposition and a preparation method and application thereof.

[0005] To achieve the above object, the technical solution adopted by the present invention is:

[0006] In a first aspect, the present invention provides a whitening nanocomposition, which comprises an active ingredient and a nanocarrier, wherein the active ingredient is coated and / or adsorbed by the nanocarrier;

[0007] The active ingredients include the following components by weight: 1-15 parts of α-arbutin, 1-15 parts of niacinamide, 1-10 parts of 3-o-ethyl ascorbic acid, 0.1-1 parts of Centella asiatica extract, and 1-5 parts of retinol palmitate;

[0008] The nanocarrier comprises the following components by weight: 5-10 parts of emulsifier, 5-20 parts of polyol, 0.1-5 parts of phospholipid and 40-60 parts of water.

[0009] The present invention uses α-arbutin, nicotinamide, 3-o-ethyl ascorbic acid, Centella asiatica extract and retinol palmitate as the main whitening active ingredients, and combines them with nano-carriers of specific components, which can not only improve the water dispersibility of the whitening nano-composition to effectively improve the solubility of the whitening active ingredients, but also enhance the stability of the whitening nano-composition to avoid unnecessary degradation or inactivation of the whitening active ingredients before storage or use, so as to increase the concentration of the functional substances in the whitening product; at the same time, the irritation of the whitening active ingredients can be reduced so that they can reach a sufficient concentration in the product to exert the corresponding functional effect. Moreover, under the action of the nano-carrier, the whitening active ingredients in the whitening nano-composition can efficiently penetrate the skin barrier, quickly reach the basal layer where melanocytes are distributed and the dermis layer located deep in the skin, and are enriched in high concentration in the target tissue, retained for a long time, and sustained and controlled release, and are effectively taken up by the target cells, thereby improving the bioavailability of the functional ingredients and prolonging the action time, thereby enhancing the whitening effect.

[0010] The above-mentioned α-arbutin, niacinamide, 3-o-ethyl ascorbic acid, Centella asiatica extract and retinol palmitate have multi-effect and multi-target synergistic effects. Among them, α-arbutin contains strong hydrophilic glucose residues, which can effectively retain moisture for the skin and easily penetrate the outer layer of the skin; at the same time, the phenolic group contained can effectively inhibit the biological activity of tyrosinase to limit and reduce the formation of cellular melanin.

[0011] Niacinamide can not only inhibit the formation of melanin particles, but also effectively inhibit the transfer of melanin to keratinocytes. When some melanin inevitably reaches the surface of the skin, niacinamide can promote the shedding of cells containing melanin by accelerating the renewal rate of skin cells. At the same time, it can also effectively inhibit the activity of tyrosinase, prevent the transfer of melanin to the stratum corneum, and promote the metabolism of cells containing melanin; it also has antioxidant properties to reduce the content of reactive oxygen species (ROS) in the skin, thereby significantly reducing spots, brightening the skin tone, and improving skin whitening.

[0012] 3-o-ethyl ascorbic acid can protect the skin from damage by free radicals to slow down the aging process of the skin. It can also inhibit the activity of tyrosinase to reduce the formation of melanin. At the same time, it can inhibit the formation of DHI (dihydroxyindole)-melanin and DHICA (dihydroxyindoleacetic acid)-melanin from tyrosine.

[0013] Centella asiatica extract is rich in polysaccharides, vitamins, flavonoids, etc. These substances can help the human body to eliminate free radicals, reduce skin pigmentation, and have multiple pharmacological effects such as antibacterial, anti-inflammatory, and promotion of fibroblast regeneration; it not only has a certain promoting effect on human fibroblast proliferation and collagen synthesis to improve scars, but also can inhibit oxidative stress, thereby exerting an anti-inflammatory and repair effect.

[0014] The main components of the Centella asiatica extract are pentacyclic triterpenoid compounds, including asiatica glycoside, madecassoside and its aglycone, asiatic acid and madecassoside, which can be purchased or prepared by existing preparation methods.

[0015] Retinyl palmitate has an antioxidant function, which can speed up the renewal of deep skin cells and promote the metabolism of growth factors, thereby improving skin metabolism and promoting the skin to produce more epidermal proteins, making the skin more elastic. At the same time, in addition to allowing the already formed keratinocytes to fall off with melanin as soon as possible, retinyl palmitate also has the ability to inhibit the formation of melanin, thus having a good whitening and brightening effect.

[0016] Optionally, the amount of α-arbutin in the above active ingredients can be 2 parts, 4 parts, 6 parts, 8 parts, 10 parts, 12 parts, or 14 parts; the amount of niacinamide can be 2 parts, 4 parts, 6 parts, 8 parts, 10 parts, 12 parts, or 14 parts; the amount of 3-o-ethyl ascorbic acid can be 3 parts, 5 parts, 7 parts, or 9 parts; the amount of Centella asiatica extract can be 0.3 parts, 0.5 parts, 0.7 parts, or 0.9 parts; and the amount of retinol palmitate can be 1.5 parts, 2.5 parts, 3.5 parts, or 4.5 parts.

[0017] Optionally, the emulsifier in the nanocarrier can be 5.5 parts, 6.5 parts, 7.5 parts, 8.5 parts, or 9.5 parts; the polyol can be 7 parts, 9 parts, 11 parts, 13 parts, 15 parts, 17 parts, or 19 parts; the phospholipid can be 0.5 parts, 1 parts, 1.5 parts, 2 parts, 2.5 parts, 3 parts, 3.5 parts, 4 parts, or 4.5 parts; and the water can be 43 parts, 45 parts, 47 parts, 49 parts, 51 parts, 53 parts, 55 parts, 57 parts, or 59 parts.

[0018] The average particle size of the whitening nanocomposite is 20-40 nm, which can be measured by a particle size analyzer.

[0019] As a preferred embodiment of the whitening nanocomposition of the present invention, the α-arbutin is 8 to 10 parts, the niacinamide is 5 to 10 parts, the 3-o-ethyl ascorbic acid is 3 to 5 parts, the Centella asiatica extract is 0.1 to 1 part, and the retinol palmitate is 1 to 3 parts.

[0020] As a preferred embodiment of the whitening nanocomposition of the present invention, the emulsifier comprises 5 to 10 parts, the polyol comprises 9 to 18 parts, the phospholipid comprises 0.5 to 1 part, and the water comprises 46 to 55 parts.

[0021] As a preferred embodiment of the whitening nanocomposition of the present invention, the mass ratio of the active ingredient to the nanocarrier is (15-30): (65-80), preferably (19.1-28.5): (69-78.5).

[0022] Optionally, in parts by weight, the active ingredient may be 20 parts, 21 parts, 22 parts, 23 parts, 24 parts, 25 parts, 26 parts, 27 parts, or 28 parts; the nanocarrier may be 70 parts, 72 parts, 74 parts, 76 parts, or 78 parts.

[0023] As a preferred embodiment of the whitening nanocomposition of the present invention, the emulsifier includes at least one of polyoxyethylene castor oil emulsifiers, polyoxyethylene hydrogenated castor oil emulsifiers, polyglycerol emulsifiers, poloxamer, and coconut glucoside.

[0024] Optionally, the above-mentioned polyoxyethylene castor oil emulsifier can specifically be at least one of polysorbate-20, polysorbate-60, polysorbate-80, etc., the polyoxyethylene hydrogenated castor oil emulsifier can specifically be at least one of PEG-40 hydrogenated castor oil, PEG-60 hydrogenated castor oil, etc., and the polyglycerol emulsifier can specifically be at least one of polyglycerol fatty acid esters, polyglycerol-10 stearate, etc.

[0025] As a preferred embodiment of the whitening nanocomposition of the present invention, the polyol includes at least one of glycerol, propylene glycol, butylene glycol, 1,3-propanediol, 1,2-pentanediol, 1,2-hexanediol, dipropylene glycol, isopropanol, polyethylene glycol-200, PPG-10 sorbitol, and octyldodecanol.

[0026] As a preferred embodiment of the whitening nanocomposition of the present invention, the phospholipid includes at least one of hydrogenated lecithin, lecithin, and soybean lecithin.

[0027] In a second aspect, the present invention provides a method for preparing the above-mentioned whitening nanocomposition, which comprises the following steps:

[0028] S1, uniformly mixing α-arbutin, niacinamide, 3-o-ethyl ascorbic acid and Centella asiatica extract, phospholipids, water and a portion of polyols to obtain a mixed solution I;

[0029] S2, mixing retinol palmitate, an emulsifier and remaining polyols uniformly to obtain a mixed solution II;

[0030] S3, mixing the mixed solution I in S1 and the mixed solution II in S2 uniformly, and homogenizing to obtain a whitening nano-composition.

[0031] The homogenization in the above step S3 can be performed by using a high-pressure homogenizer, and the pressure of the high-pressure homogenizer can specifically be 800-1000 bar.

[0032] As a preferred embodiment of the method for preparing the whitening nanocomposition of the present invention, step S1 is specifically: α-arbutin, niacinamide, 3-o-ethyl ascorbic acid and Centella asiatica extract, phospholipids, water and a portion of polyols are stirred at 40-65°C and 150-200 rpm for 10-30 min to obtain a mixed solution I.

[0033] As a preferred embodiment of the method for preparing the whitening nanocomposition of the present invention, the step S2 is specifically: stirring retinol palmitate, emulsifier and remaining polyol at 40-65° C. and 150-200 rpm for 10-30 min to obtain a mixed solution II.

[0034] As a preferred embodiment of the method for preparing the whitening nanocomposition of the present invention, the step S3 is specifically: stirring the mixed solution I in S1 and the mixed solution II in S2 at 40-65°C and 200-270rpm for 10-30 min to obtain a whitening nanocomposition.

[0035] In a third aspect, the present invention provides the use of the above-mentioned whitening nanocomposition in the preparation of skin care products or cosmetics.

[0036] In a fourth aspect, the present invention provides a whitening skin care product or whitening cosmetic comprising the above-mentioned whitening nanocomposition.

[0037] As a preferred embodiment of the whitening skin care product or whitening cosmetic of the present invention, the mass fraction of the whitening nanocomposition in the whitening skin care product or whitening cosmetic is 0.1% to 30%.

[0038] Optionally, the mass fraction of the whitening nanocomposite in the whitening skin care product or whitening cosmetic can be 0.5%, 5%, 10%, 15%, 20%, or 25%; the forms of the whitening skin care product or whitening cosmetic include but are not limited to toner, cream, lotion, essence, and gel.

[0039] Compared with the prior art, the present invention has the following beneficial effects:

[0040] The present invention uses α-arbutin, nicotinamide, 3-o-ethyl ascorbic acid, Centella asiatica extract and retinol palmitate as main whitening active ingredients, and combines them with nano-carriers of specific components, which can not only effectively improve the solubility of the whitening active ingredients, but also enhance the stability of the whitening nano-composition, and at the same time reduce the irritation of the whitening active ingredients so that they can reach a sufficient concentration in the product to exert corresponding functional effects. Moreover, the whitening active ingredients in the whitening nano-composition can efficiently penetrate the skin barrier, quickly reach the basal layer where melanocytes are distributed and the dermis layer located deep in the skin, and are enriched in high concentration in the target tissue, retained for a long time, and slowly released and controlled, and are effectively taken up by the target cells, thereby improving the bioavailability of the functional ingredients and prolonging the action time, thereby enhancing the whitening effect. BRIEF DESCRIPTION OF THE DRAWINGS

[0041] Figure 1 This is a test diagram of the chicken embryo chorioallantoic membrane irritation of the whitening nanocompositions in Examples 1 to 5 after being diluted 10 times with water;

[0042] Figure 2 This is a graph of the cumulative skin penetration of the whitening nanocomposition in Example 1 and the whitening free composition in Comparative Example 8;

[0043] Figure 3 The skin retention graph of the whitening nanocomposition in Example 1 and the whitening free composition in Comparative Example 8 (compared with the free composition, **P<0.01);

[0044] Figure 4 It is the fluorescence penetration depth diagram of free RhoB and RhoB nanocarrier of the present invention at different time;

[0045] Figure 5 It is a graph of the relative fluorescence intensity of free RhoB and RhoB nanocarrier of the present invention at different times;

[0046] Figure 6 The relative tyrosinase activity of B16F10 cells corresponding to the blank control group, model group, comparative examples 1 to 8 and Example 1 of the present invention (compared with the model group, *P<0.05, **P<0.01; compared with comparative example 6, &&P<0.01; compared with comparative example 8, ##P<0.01);

[0047] Figure 7 The relative intracellular melanin content of B16F10 cells corresponding to the blank control group, model group, comparative examples 1 to 8 and Example 1 of the present invention (compared with the model group, *P<0.05, **P<0.01; compared with comparative example 6, &&P<0.01; compared with comparative example 8, ##P<0.01);

[0048] Figure 8 Comparison charts of facial skin color and facial pigments and spots corresponding to the sample group used for volunteer 1 on day 0, day 14, and day 28;

[0049] Fig. 9 Comparison charts of facial skin color and facial pigments and spots corresponding to the sample group used for volunteer 2 on days 0, 14, and 28. DETAILED DESCRIPTION

[0050] In order to better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below in conjunction with specific embodiments.

[0051] Unless otherwise specified, other materials, reagents, etc. used in the examples can be obtained from commercial sources.

[0052] Example 1

[0053] An embodiment of the whitening nanocomposition of the present invention, the whitening nanocomposition of this embodiment comprises an active ingredient and a nanocarrier, wherein the active ingredient is coated and / or adsorbed by the nanocarrier;

[0054] The active ingredients include the following components by weight:

[0055] 10 parts of α-arbutin, 10 parts of niacinamide, 5 parts of 3-o-ethyl ascorbic acid, 0.5 parts of Centella asiatica extract, and 3 parts of retinyl palmitate;

[0056] The nanocarrier comprises the following components by weight:

[0057] Emulsifier (PEG-40 hydrogenated castor oil) 10 parts, polyol 15 parts (10 parts glycerin + 5 parts octyldodecanol), phospholipid (lecithin) 0.5 parts, water 46 parts.

[0058] The preparation method of the whitening nanocomposite described in this embodiment is:

[0059] S1. 10 parts of α-arbutin, 10 parts of niacinamide, 5 parts of 3-o-ethyl ascorbic acid, 0.5 parts of Centella asiatica extract, 0.5 parts of lecithin, 10 parts of glycerol and 46 parts of water were stirred at 45°C and 150-200 rpm for 15 min until a uniform and clear liquid A was formed;

[0060] S2, stirring 10 parts of PEG-40 hydrogenated castor oil, 5 parts of octyldodecanol and 3 parts of retinyl palmitate at 45° C. and 150-200 rpm for 15 min until a uniform and clear liquid B is formed;

[0061] S3. Add liquid A to liquid B, stir at 200-270 rpm for 15 min to form a uniform liquid C, and then homogenize liquid C twice in a high-pressure homogenizer at 800 bar to obtain a whitening nanocomposite.

[0062] Example 2

[0063] An embodiment of the whitening nanocomposition of the present invention, the whitening nanocomposition of this embodiment comprises an active ingredient and a nanocarrier, wherein the active ingredient is coated and / or adsorbed by the nanocarrier;

[0064] The active ingredients include the following components by weight:

[0065] 8 parts of α-arbutin, 6 parts of niacinamide, 4 parts of 3-o-ethyl ascorbic acid, 0.1 parts of Centella asiatica extract, and 1 part of retinyl palmitate;

[0066] The nanocarrier comprises the following components by weight:

[0067] Emulsifier (PEG-40 hydrogenated castor oil) 5 parts, polyol 18 parts (15 parts glycerin + 3 parts octyldodecanol), phospholipid (lecithin) 0.5 parts, water 55 parts.

[0068] The preparation method of the whitening nanocomposite described in this embodiment is the same as that in Example 1.

[0069] Example 3

[0070] An embodiment of the whitening nanocomposition of the present invention, the whitening nanocomposition of this embodiment comprises an active ingredient and a nanocarrier, wherein the active ingredient is coated and / or adsorbed by the nanocarrier;

[0071] The active ingredients include the following components by weight:

[0072] 8 parts of α-arbutin, 8 parts of niacinamide, 3 parts of 3-o-ethyl ascorbic acid, 1 part of Centella asiatica extract, and 1 part of retinyl palmitate;

[0073] The nanocarrier comprises the following components by weight:

[0074] Emulsifier (PEG-40 hydrogenated castor oil) 6 parts, polyol 9 parts (8 parts glycerin + 1 part octyldodecanol), phospholipid (lecithin) 1 part, water 53 parts.

[0075] The preparation method of the whitening nanocomposite described in this embodiment is the same as that in Example 1.

[0076] Example 4

[0077] An embodiment of the whitening nanocomposition of the present invention, the whitening nanocomposition of this embodiment comprises an active ingredient and a nanocarrier, wherein the active ingredient is coated and / or adsorbed by the nanocarrier;

[0078] The active ingredients include the following components by weight:

[0079] 8 parts of α-arbutin, 5 parts of niacinamide, 3 parts of 3-o-ethyl ascorbic acid, 0.5 parts of Centella asiatica extract, and 3 parts of retinyl palmitate;

[0080] The nanocarrier comprises the following components by weight:

[0081] Emulsifier (PEG-40 hydrogenated castor oil) 8 parts, polyol 13 parts (8 parts glycerin + 5 parts octyldodecanol), phospholipid (lecithin) 0.5 parts, water 55 parts.

[0082] The preparation method of the whitening nanocomposite described in this embodiment is the same as that in Example 1.

[0083] Example 5

[0084] An embodiment of the whitening nanocomposition of the present invention, the whitening nanocomposition of this embodiment comprises an active ingredient and a nanocarrier, wherein the active ingredient is coated and / or adsorbed by the nanocarrier;

[0085] The active ingredients include the following components by weight:

[0086] 10 parts of α-arbutin, 8 parts of niacinamide, 5 parts of 3-o-ethyl ascorbic acid, 0.5 parts of Centella asiatica extract, and 3 parts of retinyl palmitate;

[0087] The nanocarrier comprises the following components by weight:

[0088] Emulsifier (PEG-40 hydrogenated castor oil) 10 parts, polyol 20 parts (15 parts glycerin + 5 parts octyldodecanol), phospholipid (lecithin) 0.5 parts, water 50 parts.

[0089] The preparation method of the whitening nanocomposite described in this embodiment is the same as that in Example 1.

[0090] Example 6

[0091] An embodiment of the whitening nanocomposition of the present invention is basically the same as that of Embodiment 1, except that the emulsifier in the nanocarrier is polysorbate-80, the polyol is glycerol, and the phospholipid is soybean lecithin.

[0092] The preparation method of the whitening nanocomposite described in this embodiment is the same as that in Example 1.

[0093] Comparative Example 1

[0094] A comparative example of the whitening nanocomposition of the present invention, the whitening nanocomposition in this comparative example is substantially the same as that in Example 1, except that the active ingredient is α-arbutin (28.5 parts).

[0095] The preparation method of the whitening nanocomposition in this comparative example is the same as that in Example 1.

[0096] Comparative Example 2

[0097] A comparative example of the whitening nanocomposition of the present invention, the whitening nanocomposition in this comparative example is substantially the same as that in Example 1, except that the active ingredient is niacinamide (28.5 parts).

[0098] The preparation method of the whitening nanocomposition in this comparative example is the same as that in Example 1.

[0099] Comparative Example 3

[0100] A comparative example of the whitening nanocomposition of the present invention, the whitening nanocomposition in this comparative example is substantially the same as that in Example 1, except that the active ingredient is 3-o-ethyl ascorbic acid (28.5 parts).

[0101] The preparation method of the whitening nanocomposition in this comparative example is the same as that in Example 1.

[0102] Comparative Example 4

[0103] A comparative example of the whitening nanocomposition of the present invention, the whitening nanocomposition in this comparative example is substantially the same as that in Example 1, except that the active ingredient is Centella asiatica extract (28.5 parts).

[0104] The preparation method of the whitening nanocomposition in this comparative example is the same as that in Example 1.

[0105] Comparative Example 5

[0106] A comparative example of the whitening nanocomposition of the present invention, the whitening nanocomposition in this comparative example is substantially the same as Example 1, the difference being that the active ingredient is retinol palmitate (28.5 parts).

[0107] The preparation method of the whitening nanocomposition in this comparative example is the same as that in Example 1.

[0108] Comparative Example 6

[0109] A comparative example of the whitening nanocomposition of the present invention, the whitening nanocomposition in this comparative example is basically the same as Example 1, the difference being that the active ingredient, in parts by weight, comprises the following components:

[0110] 10 parts of α-arbutin, 10 parts of niacinamide, 5 parts of 3-o-ethyl ascorbic acid, and 0.5 parts of Centella asiatica extract;

[0111] The preparation method of the whitening nanocomposition in this comparative example is the same as that in Example 1.

[0112] Comparative Example 7

[0113] A comparative example of the whitening nanocomposition of the present invention is substantially the same as that of Example 1, except that the active ingredient is 3 parts of retinol palmitate.

[0114] The preparation method of the whitening nanocomposition in this comparative example is the same as that in Example 1.

[0115] Comparative Example 8

[0116] A comparative example of the whitening free composition of the present invention, the whitening free composition of this comparative example, in parts by weight, comprises the following components:

[0117] 10 parts of α-arbutin, 10 parts of niacinamide, 5 parts of 3-o-ethyl ascorbic acid, 0.5 parts of Centella asiatica extract, 3 parts of retinol palmitate, and 71.5 parts of a solvent (composed of dimethyl sulfoxide and water in a mass ratio of 1:9).

[0118] The preparation method of the whitening free composition described in this comparative example is:

[0119] Alpha-arbutin, niacinamide, 3-o-ethyl ascorbic acid, Centella asiatica extract, retinol palmitate and a solvent were stirred at 45°C and 150-200 rpm for 15 min to obtain a whitening free composition.

[0120] Table 1 Weight percentage of each component in Examples 1 to 6 whitening nanocompositions

[0121]

[0122] The average particle size in Table 1 above refers to the average value obtained after testing the sample three times using a particle size analyzer.

[0123] Performance Testing

[0124] 1. Stability test

[0125] The whitening nanocompositions in Examples 1 to 6 were randomly divided into Group A, Group B, Group C and Group D, and then Group A was placed at -20 °C for 3 months, Group B was placed at room temperature for 3 months, Group C was placed at 4 °C for 3 months, and Group D was placed at 45 °C for 3 months, and then observed whether stratification or chromatography occurred; the results showed that the whitening nanocompositions in each embodiment did not show stratification or precipitation under different temperature conditions. At the same time, by comparing the particle size of the whitening nanocompositions in each embodiment before and after the test, it was found that the average particle size of the whitening nanocompositions in each embodiment after being placed under different temperature conditions for 3 months did not change significantly compared to before the test, which fully demonstrated that the whitening nanocompositions of the present invention have good storage stability.

[0126] 2. Chicken embryo chorioallantoic membrane irritation test

[0127] After diluting the whitening nanocompositions in Examples 1 to 5 by 10 times with water, 200 μL was dripped onto the surface of the chick embryo chorioallantoic membrane, and the changes in blood vessels were observed and the data were recorded after waiting for 300 seconds, and the stimulation score IS was calculated. Figure 1 As shown, when the whitening nanocomposition diluted 10 times with water was in contact with the chicken embryo chorioallantoic membrane for 300 seconds, there was no capillary bleeding, vascular melting, or coagulation, and the reaction integral of Examples 1 to 5 was 0.07, indicating that the whitening nanocomposition of the present invention has good safety and is non-irritating.

[0128] 3. Patch test

[0129] 30 subjects were selected and randomly divided into 6 groups (5 people in each group), with blank essence (2.0wt% glycerol, 0.3wt% carbomer, 0.1wt% xanthan gum, 0.5wt% phenoxyethanol 0.5% and the balance of purified water) as the blank control group, and the mixture of the whitening nanocomposition and the blank essence in Examples 1 to 5 was used as the experimental group (the mass fraction of the whitening nanocomposition to the blank essence was 10%); then the experimental group and the blank control group were both attached to the curved side of the forearm of the subjects (for 24 hours), and the skin reaction was observed after the indentation disappeared. The test results showed that none of the 30 subjects had light red spots, erythema, edematous erythema, significant redness and swelling, infiltration or papules, and papules or blisters, etc., indicating that the whitening nanocomposition of the present invention is non-irritating to human skin.

[0130] 4. Cumulative penetration and skin retention test

[0131] The blank essence was composed of 2.0wt% glycerol, 0.3wt% carbomer, 0.1wt% xanthan gum, 0.5wt% phenoxyethanol 0.5% and the remaining purified water, and the whitening nanocomposition essence (blank essence + 5% of the whitening nanocomposition in Example 1 relative to the mass fraction of the blank essence) and the whitening free composition essence (blank essence + 5% of the whitening free composition in Comparative Example 8 relative to the mass fraction of the blank essence) were prepared; then the Franz diffusion cell method was used to perform a transdermal experiment on the ex vivo pig skin, and the cumulative permeation per unit area of ​​the functional ingredients in the blank essence, the whitening nanocomposition essence, and the whitening free composition essence at different times was analyzed and calculated. After 24 hours, the skin was removed, washed, cut into pieces, ground into a homogenate, centrifuged with an appropriate amount of solvent, and the supernatant was taken for HPLC analysis to calculate the skin retention per unit area of ​​the functional ingredients.

[0132] (1) Cumulative skin permeation

[0133] The cumulative skin penetration amount Q of the effective ingredients at different sampling times was calculated according to the following formula.

[0134] Q=Q n / S, where S is the area of ​​the diffusion cell 2.27cm 2 , Q n Calculated by the following formula:

[0135] ;

[0136] In the above formula, Q n is the cumulative drug permeation, C n is the drug concentration measured for the nth time, C i is the drug concentration measured at the ith point, V0 is the volume of the diffusion cell, i.e., the amount of release medium added, V i The amount of each sample.

[0137] (2) Skin Retention

[0138] The skin retention amount Q of the functional ingredients at different sampling times was calculated according to the following formula m .

[0139] Q m =C m ×V m / S, where S is the area of ​​the diffusion cell 2.27cm 2 , C m is the drug concentration measured in the skin homogenate, V m is the volume of skin homogenate.

[0140] The test results of skin cumulative penetration are as follows Figure 2 As shown by Figure 2It can be seen that the 12-hour cumulative skin permeation amount per unit area of ​​α-arbutin in the above whitening free composition essence and whitening nano composition essence is 8.16 μg / cm 2 , 29.47 μg / cm 2 The cumulative skin permeation per unit area in 24 hours was 24.68 μg / cm 2 , 98.42 μg / cm 2 That is, compared with the free whitening composition essence, the cumulative permeation of α-arbutin per unit area of ​​skin in the whitening nano-composition essence increased by 261.2% in 12 hours and 298.8% in 24 hours. The test results of skin retention are as follows Figure 3 As shown, according to Figure 3 It can be found that the skin retention of α-arbutin in the above whitening free composition essence and the whitening nano composition essence is 43.57 μg / cm 2 and 287.35 μg / cm 2 , that is, compared with the whitening free composition essence, the skin retention of α-arbutin in the whitening nano composition essence is increased by 261.2%. It can be seen that the whitening nano composition of the present invention can effectively promote the skin penetration and retention of the functional ingredients in the skin, thereby effectively improving its skin bioavailability.

[0141] 5. Observation of skin penetration behavior using laser confocal microscopy

[0142] The samples tested in "4. Cumulative permeation and skin retention test" were labeled with rhodamine B (RhoB) and frozen sliced. The skin tissue penetration behavior of free RhoB (samples corresponding to the whitening free composition essence) and RhoB nanocarriers (samples corresponding to the whitening nanocomposite essence) at different time points was observed by laser confocal microscopy. The test results are as follows: Figure 4 and Figure 5 shown.

[0143] according to Figure 4 and Figure 5It can be seen that the fluorescence penetration depth of the skin increases with time. At 4h, the depth of free RhoB entering the skin is 63.9µm, while the depth of RhoB nanocarrier entering the skin is 305.6µm, indicating that the whitening nanocomposite essence can penetrate into the deep tissue of the skin. In the same time, the relative fluorescence intensity of free RhoB at 4h is 3.8, while the relative fluorescence intensity of RhoB nanocarrier reaches 47.6, which is 11.53 times higher than that of free RhoB, that is, the fluorescence intensity of RhoB nanocarrier in the skin is significantly stronger than that of free RhoB, further proving that active nanocarriers can effectively promote the transdermal absorption of active ingredients to the target parts of the skin, thereby improving the skin bioavailability of whitening nanocomposite.

[0144] 6. Intracellular tyrosinase activity

[0145] The activity of intracellular tyrosinase was determined by L-Dopa oxidation method. B16F10 cells in logarithmic growth phase were cultured at 5.0×10 4 The cells were seeded at a density of 100 cells / well in a 24-well plate. After culturing for 24 h, the cells were divided into a control group (only DMEM complete medium was added), a model group (only DMEM complete medium containing 100 nmol / L α-MSH was added) and an experimental group (DMEM complete medium containing 100 nmol / L α-MSH + 2000-fold diluted whitening nanocompositions in Comparative Examples 1 to 7, the whitening free composition in Comparative Example 8 and the whitening nanocomposition in Example 1 was added), and 3 replicate wells were set for each group.

[0146] After 48 h of continuous culture, 200 μL of cell lysis solution containing 1% (V%) TritonX-100 was added to each well, and the cells were frozen and lysed at -80 °C for 30 min. The cell lysate was collected and centrifuged, and 100 μL of the supernatant was taken into a 96-well plate, and 100 μL of 0.1% (W / V) L-DOPA solution was added. The cells were incubated at 37 °C for 2 h, and the absorbance (A) of each well was measured at a wavelength of 495 nm using an ELISA reader. The test results are shown in Table 1. Figure 6 shown.

[0147] according to Figure 6 It can be seen that compared with the model group, Comparative Examples 1, 2, 3, 4, 6, 8 and Example 1 can significantly reduce tyrosinase activity (P<0.05 or P<0.01), while Comparative Examples 5 and 7 have no significant significance in reducing tyrosinase activity (P>0.05), indicating that retinol palmitate is difficult to effectively inhibit tyrosinase activity.

[0148] Compared with Comparative Example 6, Example 1 has a more significant effect on reducing the tyrosinase activity of B16F10 cells (P<0.01). The tyrosinase activity inhibition rate of the whitening nanocomposition composed of α-arbutin, niacinamide, 3-o-ethyl ascorbic acid and Centella asiatica extract (Comparative Example 6) is 32.3%; the tyrosinase activity inhibition rate of the whitening nanocomposition composed of α-arbutin, niacinamide, 3-o-ethyl ascorbic acid, Centella asiatica extract and retinol palmitate (Example 1) is 64.7%, that is, the tyrosinase activity inhibition rate is increased by 100.3%. It can be seen that retinol palmitate has a synergistic effect with α-arbutin, niacinamide, 3-o-ethyl ascorbic acid and Centella asiatica extract, and can significantly inhibit the intracellular tyrosinase activity.

[0149] Compared with Comparative Example 8 (tyrosinase activity inhibition rate was 34.4%), Example 1 had a more significant effect on reducing tyrosinase activity in B16F10 cells (P<0.01), and the tyrosinase activity inhibition rate was increased by 88.1%, which fully demonstrated that the nanocarrier can enhance the tyrosinase activity inhibition rate of the active ingredient, thereby significantly improving the whitening effect of the whitening nanocomposition.

[0150] 7. Determination of cell melanin content and observation of its production

[0151] The NaOH lysis method was used to determine the content of intracellular melanin. B16F10 cells in the logarithmic growth phase were cultured at 5.0×10 4 The cells were seeded at a density of 100 cells / well in a 24-well plate. After culturing for 24 h, the cells were divided into a control group (only DMEM complete medium was added), a model group (only DMEM complete medium containing 100 nmol / L α-MSH was added) and an experimental group (DMEM complete medium containing 100 nmol / L α-MSH + 2000-fold diluted whitening nanocompositions in Comparative Examples 1 to 7, the whitening free composition in Comparative Example 8 and the whitening nanocomposition in Example 1 was added), and 3 replicate wells were set for each group.

[0152] After culturing for 48 h, the cells in each well were collected into centrifuge tubes, 200 μL of 1 mol / L NaOH solution containing 10% DMSO was added to each centrifuge tube, and the EP tube was placed in a constant temperature water bath at 80 °C for 1 h to lyse the cells and dissolve the melanin. The supernatant was collected and placed in a 96-well plate. The absorbance (A) of each well was measured at a wavelength of 405 nm using an ELISA reader. The test results are shown in Figure 2. Figure 7 shown.

[0153] according to Figure 7It can be found that compared with the model group, Comparative Examples 1, 2, 3, 4, 6, 8 and Example 1 can significantly reduce the intracellular melanin content (P<0.05 or P<0.01), while Comparative Examples 5 and 7 have no significant significance in reducing the intracellular melanin content (P>0.05), indicating that retinol palmitate is difficult to effectively inhibit the intracellular melanin content.

[0154] Compared with Comparative Example 6, Example 1 has a more significant effect on reducing the intracellular melanin content of B16F10 cells (P<0.01). The whitening nanocomposition composed of α-arbutin, niacinamide, 3-o-ethyl ascorbic acid and Centella asiatica extract (Comparative Example 6) has an intracellular melanin content inhibition rate of 75.4%; the whitening nanocomposition composed of α-arbutin, niacinamide, 3-o-ethyl ascorbic acid, Centella asiatica extract and retinol palmitate (Example 1) has an intracellular melanin content inhibition rate of 43.2%, that is, the intracellular melanin content inhibition rate is increased by 130.1%. It can be seen that retinol palmitate has a synergistic effect with α-arbutin, niacinamide, 3-o-ethyl ascorbic acid and Centella asiatica extract, which can significantly reduce the intracellular melanin content. At the same time, compared with Comparative Example 8, the inhibition rate of intracellular melanin content in Example 1 was increased by 111.2%, which fully demonstrated that retinol palmitate has a synergistic effect with α-arbutin, niacinamide, 3-o-ethyl ascorbic acid, and Centella asiatica extract, which can significantly promote the improvement of the effect of whitening active ingredients, and the nanocarrier can further enhance the effect of whitening active ingredients.

[0155] 8. Human efficacy evaluation test

[0156] The blank essence solution was composed of 2.0wt% glycerol, 0.3wt% carbomer, 0.1wt% xanthan gum, 0.5wt% phenoxyethanol 0.5% and the balance purified water.

[0157] Control group 1: blank essence;

[0158] Control group 2: blank essence + 5% of the whitening nanocomposition in comparative example 1 relative to the mass fraction of the blank essence;

[0159] Control group 3: blank essence + 5% of the whitening nanocomposition in comparative example 2 relative to the mass fraction of the blank essence;

[0160] Control group 4: blank essence + 5% of the whitening nanocomposition in comparative example 3 relative to the mass fraction of the blank essence;

[0161] Control group 5: blank essence + 5% of the whitening nanocomposition in comparative example 4 relative to the mass fraction of the blank essence;

[0162] Control group 6: blank essence + 5% of the whitening nanocomposition in comparative example 5 relative to the mass fraction of the blank essence;

[0163] Control group 7: blank essence + 5% of the whitening nanocomposition in comparative example 6 relative to the mass fraction of the blank essence;

[0164] Control group 8: blank essence + 5% of the whitening nanocomposition in comparative example 7 relative to the mass fraction of the blank essence;

[0165] Control group 9: blank essence + 5% of the whitening free composition in Comparative Example 8 relative to the mass fraction of the blank essence;

[0166] Sample group: blank essence + 5% of the whitening nanocomposition in Example 1 relative to the mass fraction of the blank essence.

[0167] 30 experimental volunteers were recruited, aged between 20 and 60 years old, healthy, without skin diseases, not pregnant or breastfeeding, and not allergic to product ingredients. After informing the evaluation process, possible effects, risks, precautions and signing the informed consent for efficacy evaluation, they were randomly divided into 10 groups (3 people in each group) to conduct efficacy evaluation tests on the above control groups and sample groups. The samples were used on the face twice a day on a regular basis. Other products or drugs that may affect the skin condition were not allowed to be used during the test. The skin condition and feelings after use were recorded and fed back accurately. After applying the samples for 4 weeks (28 days), the efficacy indicators of the volunteers were observed and compared. The Shanghai Fuhuan Vplus® Intelligent Skin Analysis System and the German CK Skin Melanin Tester MX18 were used to measure the facial skin color and uniformity (ITA°) angle, skin gloss (L value), total area of ​​melanin and spots, and MI value of melanin and spots. The changes in each index parameter after using the sample were calculated and the average was taken.

[0168] Table 2 Changes in skin indicators of volunteers before and after using samples

[0169]

[0170] According to the data in Table 2, after the volunteers used the control group 1 (blank essence) for 4 weeks, the ITA value increased by 0.31%, the skin L* value increased by 0.22%, the MI value decreased by 0.54%, and the melanin spot area decreased by 0.15%. In other words, there was no significant change in the above indicators, indicating that the blank essence had no effect on improving skin color and uniformity, melanin and spots.

[0171] Compared with control group 1, the skin ITA° and L* values ​​of volunteers in control groups 2 to 7, control group 9 and the sample group were significantly improved, and the MI value and the total area of ​​melanin spots were significantly reduced after 4 weeks of use; the improvement in whitening effect of control group 8 was limited due to the low content of retinol palmitate. Among them, the effect of control group 7 (a whitening nanocomposite composed of α-arbutin, niacinamide, 3-o-ethyl ascorbic acid and Centella asiatica extract) was significantly improved, with an ITA value increased by 6.58%, an L* value increased by 5.16%, a MI value decreased by 8.47%, and a total area of ​​melanin spots decreased by 10.28%; while the whitening nanocomposite composed of α-arbutin, niacinamide, 3-o-ethyl ascorbic acid, Centella asiatica extract and retinol palmitate + blank essence (sample group), after use, the ITA value increased by 11.08%, the L* value increased by 11.43%, the MI value decreased by 18.67%, and the total area of ​​melanin spots decreased by 21.42%, which fully demonstrates that there is a synergistic whitening effect between α-arbutin, niacinamide, 3-o-ethyl ascorbic acid, Centella asiatica extract and retinol palmitate.

[0172] In addition, after using the control group 9 (whitening free composition + blank essence in comparative example 8), the ITA value increased by 6.86%, the L* value increased by 5.96%, the MI value decreased by 9.15%, and the total area of ​​melanin spots decreased by 10.76%, that is, its whitening effect was weaker than that of the sample group. It can be seen that the whitening active ingredients can be effectively combined with nanocarriers to improve skin color and uniformity, melanin and spot effects.

[0173] Figure 8 and Fig. 9 Comparison chart of facial skin color of different volunteers using sample groups on day 0, day 14, and day 28 ( Figure 8 A. Fig. 9 A) and facial pigmentation and spots comparison chart ( Figure 8 B. Fig. 9 B), all collected by Vplus equipment. Figure 8 and Fig. 9 It can be seen that after using 5% of the whitening nano-composition essence in Example 1 for 28 days, the number and average area of ​​melanin and spots on the volunteers' faces decreased, and the uniformity and glossiness of their skin color were significantly improved, with excellent whitening effects.

[0174] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit the scope of protection of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present invention.

Claims

1. A whitening nanocomposite, It is characterized in that Comprising an active ingredient and a nanocarrier, wherein the active ingredient is coated and / or adsorbed by the nanocarrier; The active ingredient is composed of the following components by weight: 1-15 parts of α-arbutin, 1-15 parts of niacinamide, 1-10 parts of 3-o-ethyl ascorbic acid, 0.1-1 parts of Centella asiatica extract and 1-5 parts of retinol palmitate; The nanocarrier is composed of the following components by weight: 5-10 parts of emulsifier, 5-20 parts of polyol, 0.1-5 parts of phospholipid and 40-60 parts of water; The average particle size of the whitening nanocomposite is 20-40 nm; The emulsifier is PEG-40 hydrogenated castor oil and / or polysorbate-80, and the polyol is glycerol and / or octyl dodecanol.

2. The whitening nanocomposite according to claim 1, It is characterized in that The mass ratio of the active ingredient to the nanocarrier is (15-30): (65-80).

3. The whitening nanocomposite according to claim 1 or 2, It is characterized in that The phospholipid is lecithin.

4. The whitening nanocomposite according to claim 3, It is characterized in that The lecithin is at least one of hydrogenated lecithin and soybean lecithin.

5. A method for preparing the whitening nanocomposition according to any one of claims 1 to 4, It is characterized in that The following steps are involved: S1, uniformly mixing α-arbutin, niacinamide, 3-o-ethyl ascorbic acid and Centella asiatica extract, phospholipids, water and a portion of polyols to obtain a mixed solution I; S2, mixing retinol palmitate, an emulsifier and remaining polyols uniformly to obtain a mixed solution II; S3, mixing the mixed solution I in S1 and the mixed solution II in S2 uniformly, and homogenizing to obtain a whitening nano-composition.

6. The method for preparing the whitening nanocomposite according to claim 5, It is characterized in that Including at least one of the following (I) to (III): (I) The step S1 specifically comprises: stirring α-arbutin, nicotinamide, 3-o-ethyl ascorbic acid and Centella asiatica extract, phospholipids, water and a portion of polyols at 40-65° C. and 150-200 rpm for 10-30 min to obtain a mixed solution I; (II) The step S2 specifically comprises: stirring retinol palmitate, an emulsifier and the remaining polyol at 40-65° C. and 150-200 rpm for 10-30 min to obtain a mixed solution II; (III) The step S3 is specifically as follows: stirring the mixed solution I in S1 and the mixed solution II in S2 at 40-65° C. and 200-270 rpm for 10-30 min to obtain a whitening nanocomposite.

7. Use of the whitening nanocomposition according to any one of claims 1 to 4 in the preparation of skin care products or cosmetics.

8. A whitening skin care product or whitening cosmetic comprising the whitening nano composition according to any one of claims 1 to 4.

9. The whitening skin care product or whitening cosmetic according to claim 8, It is characterized in that The mass fraction of the whitening nanocomposite in the whitening skin care product or whitening cosmetic is 0.1% to 30%.